Douglas Reed
Director/Board Member bij Viamet Pharmaceuticals Corp.
Profiel
Douglas W.
Reed is currently the Chairman at Innocrin Pharmaceuticals Holdings LLC since 2014.
He is also the Director at Viamet Pharmaceuticals, Inc. since 2007, the Director at Contego Medical, Inc., the Director at Viamet Pharmaceuticals Corp.
since 2011, the Director at Southeast BIO since 2009, the Director at Innocrin Pharmaceuticals, Inc., the Director at Standard Bariatrics, Inc., the Director at Qpex Biopharma, Inc., the General Partner at Hatteras Venture Affiliates III LP, and the General Partner at Hatteras Venture Partners since 2007.
In the past, Dr. Reed worked as the Director at Star Equity Holdings, Inc. from 2000 to 2009.
He was also the Director at PhaseBio Pharmaceuticals, Inc. from 2007 to 2009, the Independent Director at TetraLogic Pharmaceuticals Corp.
from 2010 to 2016, and the Director at Gilead Connecticut, Inc. from 2001 to 2010.
Additionally, he served as the Vice President-Business Development at NPS Pharmaceuticals, Inc. in 1996 and 1997, and at GelTex Pharmaceuticals, Inc. in 1998 and 1999.
He was a Principal at GSK Equity Investments Ltd.
from 1989 to 1995, and an Assistant Professor at the University of Washington in 1983.
Dr. Reed obtained his undergraduate and doctorate degrees from the University of Missouri-Kansas City in 1977 and 1978, respectively.
He also holds an MBA from The Wharton School of the University of Pennsylvania, which he received in 1989.
Actieve functies van Douglas Reed
Bedrijven | Functie | Begin |
---|---|---|
Qpex Biopharma, Inc.
Qpex Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Qpex Biopharma, Inc. develops a pipeline of agents addressing critical needs for the treatment of infectious diseases in the inpatient and outpatient settings. The company is headquartered in San Diego, CA. | Director/Board Member | - |
Innocrin Pharmaceuticals Holdings LLC
Innocrin Pharmaceuticals Holdings LLC Medical SpecialtiesHealth Technology Innocrin Pharmaceuticals Holdings LLC discovers and develops oral inhibitors for the treatment of Castration-Resistant Prostate Cancer (CRPC). The company is headquartered in Durham, NC. | Chairman | 01-01-2014 |
Innocrin Pharmaceuticals, Inc.
Innocrin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Innocrin Pharmaceuticals, Inc. develops oral inhibitors for the treatment of castration-resistant prostate cancer. It develops small molecule CYP17 lyase-selective inhibitors to treat resistant hormonally-dependent breast and prostate cancers. The firm’s product under pipeline is VT-464, a dual mechanism lyase-selective CYP17 inhibitor and androgen receptor (AR) antagonist that disrupts the validated biochemical pathways required for prostate cancer growth androgen biosynthesis and AR transcriptional signaling. The company was founded in 2004 and is headquartered in Durham, NC. | Director/Board Member | - |
Contego Medical, Inc.
Contego Medical, Inc. Medical SpecialtiesHealth Technology Contego Medical LLC develops novel emboli protection devices. Its products include CORGUARD coronary stent system, VANGUARD renal stent system, and PALADIN carotid post-dilation balloon. The company was founded by Ravish Sachar and Jay S. Yadav in 2005 and is headquartered in Raleigh, NC. | Director/Board Member | - |
Southeast BIO | Director/Board Member | 01-01-2009 |
Viamet Pharmaceuticals, Inc.
Viamet Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Viamet Pharmaceuticals, Inc. discovers and develops inhibitors of validated metalloenzymes. The firm's clinical portfolio includes novel agents to treat both chronic and life threatening fungal infections. It also leverage our metalloenzyme expertise in other therapeutic areas including oncology and orphan diseases. The company was founded by Thomas V. O’Halloran and Holden H. Thorp on August 18, 2005 and is headquartered in Durham, NC. | Director/Board Member | 01-05-2007 |
Hatteras Venture Affiliates III LP | Corporate Officer/Principal | - |
Viamet Pharmaceuticals Corp.
Viamet Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Viamet Pharmaceuticals Corp. engages in the discovery, development, and commercialization of novel pharmaceuticals based on its proprietary metalloenzyme chemistry and biology technology platform. Its clinical portfolio includes novel agents to treat chronic and life threatening fungal infections. Its products include VT-1161, an oral agent that treats onychomycosis; VT-1129, which treats cryptococcal meningitis; and VT-1598, that treats coccidioidomycosis. The company was founded by Herbert Holden Thorp and Thomas V. O'Halloran in December 2011 and is headquartered in Durham, NC. | Director/Board Member | 01-12-2011 |
Hatteras Venture Partners
Hatteras Venture Partners Investment ManagersFinance Hatteras Venture Partners (Hatteras Venture) is venture capital firm founded in 2000 by Clay B. Thorp and John Crumpler. The firm is headquartered in Durham, North Carolina. | Private Equity Investor | 01-01-2007 |
░░░░░░░░ ░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
Eerdere bekende functies van Douglas Reed
Bedrijven | Functie | Einde |
---|---|---|
░░░░░░░░░░ ░░░░░░░░░░░░░░░ ░░░░░░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░ ░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
░░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
░░░░ ░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
Opleiding van Douglas Reed
University of Missouri-Kansas City | Doctorate Degree |
The Wharton School of the University of Pennsylvania | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 3 |
---|---|
STAR EQUITY HOLDINGS, INC. | Health Technology |
PHASEBIO PHARMACEUTICALS, INC. | Health Technology |
TETRALOGIC PHARMACEUTICALS CORPORATION | Health Technology |
Bedrijven in privébezit | 21 |
---|---|
NPS Pharmaceuticals, Inc.
NPS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology NPS Pharmaceuticals, Inc. developed drugs for bone and mineral disorders. It also developed Natpara for the treatment of adult hypoparathyroidism. The company was founded by Hunter Jackson and Thomas N. Parks on October 22, 1986 and is headquartered in Bedminster, NJ. | Health Technology |
GelTex Pharmaceuticals, Inc.
GelTex Pharmaceuticals, Inc. BiotechnologyHealth Technology GelTex Pharmaceuticals, Inc. was developed non-absorbed, polymer-based pharmaceuticals that selectively bind and eliminate target substances from the intestinal tract. The company is a subsidiary of Geltex Corp. GelTex Pharmaceuticals was founded by Henry E Blair & James B Tananbaum in 1991 and was located in Waltham, MA. | Health Technology |
Viamet Pharmaceuticals, Inc.
Viamet Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Viamet Pharmaceuticals, Inc. discovers and develops inhibitors of validated metalloenzymes. The firm's clinical portfolio includes novel agents to treat both chronic and life threatening fungal infections. It also leverage our metalloenzyme expertise in other therapeutic areas including oncology and orphan diseases. The company was founded by Thomas V. O’Halloran and Holden H. Thorp on August 18, 2005 and is headquartered in Durham, NC. | Health Technology |
Hatteras Venture Affiliates III LP | Finance |
SpineAlign Medical, Inc.
SpineAlign Medical, Inc. Medical SpecialtiesHealth Technology SpineAlign Medical, Inc. operates as a medical device company which develops implantable products to treat vertebral compression fractures. Its nitinol implant is designed to improve the lumbar spines. The firm’s implants are designed to support vertebral endplates, reducing the fracture and maintaining lift until bone cement is injected. The company was founded by Paul E. Chirico in 2005 and is headquartered in San Jose, CA. | Health Technology |
Contego Medical, Inc.
Contego Medical, Inc. Medical SpecialtiesHealth Technology Contego Medical LLC develops novel emboli protection devices. Its products include CORGUARD coronary stent system, VANGUARD renal stent system, and PALADIN carotid post-dilation balloon. The company was founded by Ravish Sachar and Jay S. Yadav in 2005 and is headquartered in Raleigh, NC. | Health Technology |
BlinkBio, Inc.
BlinkBio, Inc. Pharmaceuticals: MajorHealth Technology BlinkBio, Inc. operates as a biotechnology company. It develops medicines for the treatment of cancer and other diseases. The company was founded by Maneesh Pingle, Francis Barany, Don Bergstrom and Michael Gargano in 2009 and is headquartered in Juno Beach, FL. | Health Technology |
Viamet Pharmaceuticals Corp.
Viamet Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Viamet Pharmaceuticals Corp. engages in the discovery, development, and commercialization of novel pharmaceuticals based on its proprietary metalloenzyme chemistry and biology technology platform. Its clinical portfolio includes novel agents to treat chronic and life threatening fungal infections. Its products include VT-1161, an oral agent that treats onychomycosis; VT-1129, which treats cryptococcal meningitis; and VT-1598, that treats coccidioidomycosis. The company was founded by Herbert Holden Thorp and Thomas V. O'Halloran in December 2011 and is headquartered in Durham, NC. | Health Technology |
NeuroTronik, Inc.
NeuroTronik, Inc. Information Technology ServicesTechnology Services NeuroTronik, Inc. develops medical technology for commercial operations. The company is headquartered in Chapel Hill, NC. | Technology Services |
Sideris Pharmaceuticals, Inc.
Sideris Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sideris Pharmaceuticals, Inc. operated as a biopharmaceutical company. It focused on development of therapeutics for the treatment of transfusion related iron overload. The company was founded by Raymond Bergeron and Thomas Neenan on June 1, 2012 and was headquartered in Lexington, MA. | Health Technology |
Innocrin Pharmaceuticals Holdings LLC
Innocrin Pharmaceuticals Holdings LLC Medical SpecialtiesHealth Technology Innocrin Pharmaceuticals Holdings LLC discovers and develops oral inhibitors for the treatment of Castration-Resistant Prostate Cancer (CRPC). The company is headquartered in Durham, NC. | Health Technology |
GSK Equity Investments Ltd.
GSK Equity Investments Ltd. Investment ManagersFinance GSK Equity Investment Ltd (GSK Equity) is a venture capital firm a subsidiary of GlaxoSmithKline Plc founded in 1985. The firm is headquartered in Reedwood City, California. | Finance |
Gilead Connecticut, Inc.
Gilead Connecticut, Inc. Pharmaceuticals: MajorHealth Technology Gilead Connecticut, Inc. manufactures pharmaceuticals and biotechnology chemicals. The firm develops a pipeline of small molecule therapeutics for multiple oncology and immunology-based indications. It focuses on the development of novel kinase inhibitors for the treatment of cancer, autoimmune, and inflammatory diseases. The company was founded in 2000 and is headquartered in Foster City, CA. | Health Technology |
Hatteras Venture Partners
Hatteras Venture Partners Investment ManagersFinance Hatteras Venture Partners (Hatteras Venture) is venture capital firm founded in 2000 by Clay B. Thorp and John Crumpler. The firm is headquartered in Durham, North Carolina. | Finance |
Southeast BIO | |
Vector Asset Management, Inc.
Vector Asset Management, Inc. Investment ManagersFinance Vector Asset Management, Inc. is a venture capital firm based in Deerfield, Illinois | Finance |
Embrella Cardiovascular, Inc.
Embrella Cardiovascular, Inc. Miscellaneous Commercial ServicesCommercial Services Embrella Cardiovascular, Inc. develops proprietary systems for embolic cerebral protection during cardiovascular procedures. The company was founded by Judith T. Carpenter and Jeffrey Francis O'Donnell, Sr. in 2007 and is headquartered in Wayne, PA. | Commercial Services |
First National Bank of Crossett (Arkansas)
First National Bank of Crossett (Arkansas) Major BanksFinance First National Bank of Crossett provides commercial banking services. It offers personal and business banking services. The company is headquartered in Hamburg, AR. | Finance |
Standard Bariatrics, Inc.
Standard Bariatrics, Inc. Medical SpecialtiesHealth Technology Standard Bariatrics, Inc. operates as a surgical procedure company focused on the development and commercialization of medical devices. It offers STANDARD CLAMP, a laparoscopic surgical device designed to clamp the entire length of the stomach, enabling surgeons to plan and hold the staple line prior to dividing the stomach during laparoscopic sleeve gastrectomy. The company was founded by Jonathan Thompson in 2014 and is headquartered in Cincinnati, OH. | Health Technology |
Qpex Biopharma, Inc.
Qpex Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Qpex Biopharma, Inc. develops a pipeline of agents addressing critical needs for the treatment of infectious diseases in the inpatient and outpatient settings. The company is headquartered in San Diego, CA. | Health Technology |
Innocrin Pharmaceuticals, Inc.
Innocrin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Innocrin Pharmaceuticals, Inc. develops oral inhibitors for the treatment of castration-resistant prostate cancer. It develops small molecule CYP17 lyase-selective inhibitors to treat resistant hormonally-dependent breast and prostate cancers. The firm’s product under pipeline is VT-464, a dual mechanism lyase-selective CYP17 inhibitor and androgen receptor (AR) antagonist that disrupts the validated biochemical pathways required for prostate cancer growth androgen biosynthesis and AR transcriptional signaling. The company was founded in 2004 and is headquartered in Durham, NC. | Health Technology |